Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susan N. Rossmann is active.

Publication


Featured researches published by Susan N. Rossmann.


American Journal of Tropical Medicine and Hygiene | 2015

Case Report: Evidence of Autochthonous Chagas Disease in Southeastern Texas

Melissa N. Garcia; David Aguilar; Rodion Gorchakov; Susan N. Rossmann; Susan P. Montgomery; Hilda Rivera; Laila Woc-Colburn; Peter J. Hotez; Kristy O. Murray

Autochthonous transmission of Trypanosoma cruzi in the United States is rarely reported. Here, we describe five newly identified patients with autochthonously acquired infections from a small pilot study of positive blood donors in southeast Texas. Case-patients 1-4 were possibly infected near their residences, which were all in the same region ∼100 miles west of Houston. Case-patient 5 was a young male with considerable exposure from routine outdoor and camping activities associated with a youth civic organization. Only one of the five autochthonous case-patients received anti-parasitic treatment. Our findings suggest an unrecognized risk of human vector-borne transmission in southeast Texas. Education of physicians and public health officials is crucial for identifying the true disease burden and source of infection in Texas.


Transfusion | 2008

Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening.

Jed B. Gorlin; Susan N. Rossmann; Gene Robertson; Fred Stallone; Nora V. Hirschler; Kim-Anh Nguyen; Ronald O. Gilcher; Helen Fernandes; Stacey Alvey; Patience Ajongwen; Paul Contestable; Harold Warren

BACKGROUND: This multicenter prospective study was designed to evaluate the performance characteristics of a new commercially available enzyme‐linked immunosorbent assay (ELISA) for the detection of antibodies to Trypanosoma cruzi in blood donors, the ORTHO T. cruzi ELISA Test System (Ortho‐Clinical Diagnostics).


PLOS ONE | 2014

Survival Analysis, Long-Term Outcomes, and Percentage of Recovery up to 8 Years Post-Infection among the Houston West Nile Virus Cohort

Kristy O. Murray; Melissa N. Garcia; Mohammad H. Rahbar; Diana Martinez; Salma A. Khuwaja; Raouf R. Arafat; Susan N. Rossmann

In 2012, we witnessed a resurgence of West Nile virus (WNV) in the United States, with the largest outbreak of human cases reported since 2003. WNV is now endemic and will continue to produce epidemics over time, therefore defining the long-term consequences of WNV infection is critical. Over a period of eight years, we prospectively followed a cohort of 157 WNV-infected subjects in the Houston metropolitan area to observe recovery over time and define the long-term clinical outcomes. We used survival analysis techniques to determine percentage of recovery over time and the effects of demographic and co-morbid conditions on recovery. We found that 40% of study participants continued to experience symptoms related to their WNV infection up to 8 years later. Having a clinical presentation of encephalitis and being over age 50 were significantly associated with prolonged or poor recovery over time. Since the health and economic impact as a result of prolonged recovery, continued morbidity, and related disability is likely substantial in those infected with WNV, future research should be aimed at developing effective vaccines to prevent illness and novel therapeutics to minimize morbidity, mortality, and long-term complications from infection.


Transfusion | 2017

First Zika-positive donations in the continental United States

Susan A. Galel; Phillip C. Williamson; Michael P. Busch; Danielle Stanek; Sonia Bakkour; Mars Stone; Kai Lu; Scott Jones; Susan N. Rossmann; Lisa Lee Pate

Zika virus (ZIKV) has spread in the Americas, including parts of the southern United States, and infection can be associated with serious complications, including congenital brain abnormalities. Probable transfusion transmission of ZIKV has been documented in Brazil.


Biology of Blood and Marrow Transplantation | 2015

Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

Navneet S. Majhail; Pintip Chitphakdithai; Brent R. Logan; Roberta J. King; Steven M. Devine; Susan N. Rossmann; Gregory A. Hale; R.J. Hartzman; Chatchada Karanes; Ginna G. Laport; Eneida R. Nemecek; Edward L. Snyder; Galen E. Switzer; John P. Miller; Willis H. Navarro; Dennis L. Confer; John E. Levine

Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy because of the mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this information, we evaluated 15,059 unrelated donor hematopoietic cell transplant recipients between 2000 and 2009. We compared outcomes before and after 2005 for 4 cohorts: age <18 years with malignant diseases (n = 1920), ages 18 to 59 years with malignant diseases (n = 9575), ages ≥ 60 years with malignant diseases (n = 2194), and nonmalignant diseases (n = 1370). Three-year overall survival in 2005 to 2009 was significantly better in all 4 cohorts (<18 years: 55% versus 45%, 18 to 59 years: 42% versus 35%, ≥ 60 years: 35% versus 25%, nonmalignant diseases: 69% versus 60%; P < .001 for all comparisons). Multivariate analyses in leukemia patients receiving HLA 7/8 to 8/8-matched transplants showed significant reduction in overall and nonrelapse mortality in the first year after HCT among patients who underwent transplantation in 2005 to 2009; however, risks for relapse did not change over time. Significant survival improvements after unrelated donor HCT have occurred over the recent decade and can be partly explained by better patient selection (eg, HCT earlier in the disease course and lower disease risk), improved donor selection (eg, more precise allele-level matched unrelated donors) and changes in transplantation practices.


Epidemiology and Infection | 2016

Trypanosoma cruzi screening in Texas blood donors, 2008–2012

Melissa N. Garcia; Laila Woc-Colburn; Susan N. Rossmann; R. L. Townsend; S. L. Stramer; M. Bravo; H. Kamel; R. Beddard; M. Townsend; R. Oldham; Maria Elena Bottazzi; Peter J. Hotez; Kristy O. Murray

Chagas disease is an important emerging disease in Texas that results in cardiomyopathy in about 30% of those infected with the parasite Trypanosoma cruzi. Between the years 2008 and 2012, about 1/6500 blood donors were T. cruzi antibody-confirmed positive. We found older persons and minority populations, particularly Hispanic, at highest risk for screening positive for T. cruzi antibodies during routine blood donation. Zip code analysis determined that T. cruzi is associated with poverty. Chagas disease has a significant disease burden and is a cause of substantial economic losses in Texas.


BioMed Research International | 2012

Proximity of Residence to Bodies of Water and Risk for West Nile Virus Infection: A Case-Control Study in Houston, Texas

Melissa S. Nolan; Ana Zangeneh; Salma A. Khuwaja; D. Martinez; Susan N. Rossmann; Victor Cardenas; Kristy O. Murray

West Nile virus (WNV), a mosquito-borne virus, has clinically affected hundreds of residents in the Houston metropolitan area since its introduction in 2002. This study aimed to determine if living within close proximity to a water source increases ones odds of infection with WNV. We identified 356 eligible WNV-positive cases and 356 controls using a population proportionate to size model with US Census Bureau data. We found that living near slow moving water sources was statistically associated with increased odds for human infection, while living near moderate moving water systems was associated with decreased odds for human infection. Living near bayous lined with vegetation as opposed to concrete also showed increased risk of infection. The habitats of slow moving and vegetation lined water sources appear to favor the mosquito-human transmission cycle. These methods can be used by resource-limited health entities to identify high-risk areas for arboviral disease surveillance and efficient mosquito management initiatives.


Emerging Infectious Diseases | 2017

Likely Autochthonous Transmission of Trypanosoma cruzi to Humans, South Central Texas, USA

Sarah M. Gunter; Kristy O. Murray; Rodion Gorchakov; Rachel Beddard; Susan N. Rossmann; Susan P. Montgomery; Hilda Rivera; Eric L. Brown; David Aguilar; Lawrence E. Widman; Melissa N. Garcia

Chagas disease, caused by Trypanosoma cruzi, is a major neglected tropical disease affecting the Americas. The epidemiology of this disease in the United States is incomplete. We report evidence of likely autochthonous vectorborne transmission of T. cruzi and health outcomes in T. cruzi–seropositive blood donors in south central Texas, USA.


Transfusion | 2004

Particulate matter phenomenon: adverse event data and the effect of leukofiltration

Sharyn L. Orton; German F. Leparc; Susan N. Rossmann; R.M. Lewis

BACKGROUND:  In February 2002, a multiorganizational task force investigated blood center reports of unusual particulate matter (PM) visible in packed red blood cells (RBC). A cohort study assessed increase in adverse events (AEs) related to this phenomenon, as well as the effect of post‐leukofiltration (LF) on PM.


Transfusion | 2018

Changes in plasma unit distributions to hospitals over a 10-year period: PLASMA DISTRIBUTIONS TO HOSPITALS

Jansen Seheult; Beth H. Shaz; Marjorie Bravo; Harry Croxon; Dana V. Devine; Cheryl Doncaster; Stephen Field; Peter Flanagan; Marc Germain; Yves Grégoire; Hany Kamel; Matthew S. Karafin; Nancy Kelting; Marc Lewis; Cath O'Brien; Michael F. Murphy; Susan N. Rossmann; Merlyn Sayers; Eilat Shinar; Minoko Takanashi; Kjell Titlestad; Mark H. Yazer

There are many influences on a hospitals demand for plasma. Pharmaceuticals are now being administered for many indications instead of plasma, although trauma resuscitation now emphasizes increased and early intervention with plasma. This multinational study evaluated changes in blood center plasma unit distributions over a 10‐year period.

Collaboration


Dive into the Susan N. Rossmann's collaboration.

Top Co-Authors

Avatar

Kristy O. Murray

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Melissa N. Garcia

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Laila Woc-Colburn

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Rodion Gorchakov

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

David Aguilar

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Peter J. Hotez

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Chatchada Karanes

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dennis L. Confer

National Marrow Donor Program

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge